News
age-related macular degeneration
Researchers working on possible alternative treatment for wet AMD
Researchers have recently discovered that the enzyme, telomerase, plays a role in abnormal blood vessel formation in lab mice and this discovery may lead to new therapies in treating the wet form ...
age-related macular degeneration
Retrospective study suggests melatonin may decrease risk development of macular degeneration
Melatonin has antioxidant properties and researchers sought to discover if it might provide benefits for eye health.
age-related macular degeneration
Low-dose aspirin offers no benefit against macular degeneration
Australian researchers recently published the results of a study that examined the effects of low-dose aspirin on age-related macular degeneration.
age-related macular degeneration
Study shines light on Saffron's positive affects on vision
Despite it's hefty price tag, saffron, which is a powerful antioxidant, is a popular dietary supplement used for a wide range of ailments including the improvement of cognitive function, mood boost...
age-related macular degeneration
Minocycline offers no benefit in treating dry age-related macular degeneration
Minocycline, a commonly prescribed antibiotic that also offers anti-inflammatory effects, does not offer any benefits to those suffering from dry age-related macular degeneration.
age related macular degeneration
Something out of science fiction: solar panels for the eyes
With new treatments and scientific advancements being announced almost on a daily basis, it shouldn't be surprising that the next "big thing" might very well be tiny solar panels for the eyes.
age related macular degeneration
Visual hallucinations commonly associated with age-related macular degeneration
Charles Bonnet Syndrome (CBS) is a condition that occurs when people lose some or all of their vision.
age-related macular degeneration
Artificial outdoor nighttime lights linked to higher risk of macular degeneration
A study published in JAMA Network Open details the possible link of exposure to nighttime artificial outdoor lights and an increased risk of age-related macular degeneration.
Researchers at Jeju N...
age related macular degeneration
Phase 2b clinical trials set for potential AMD treatment
More than one million Americans aged 40 and over are affected by geographic atrophy (otherwise known as advanced dry age-related macular degeneration), which currently has no available therapy that...